Tag: filing

RENO, Nev., June 12, 2025 (GLOBE NEWSWIRE) -- GreetEat Corporation (OTC: GEAT) is proud to announce that it has officially filed a patent application for its innovative core technology: “Video Conferencing with Food Delivery Vouchers.” The company is now patent pending, marking a major milestone in its mission to transform the way people meet, connect, and collaborate in virtual environments.

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on continued momentum with United States Food and Drug Administration (FDA) regarding both accelerated approval pathway for Revascor^® (rexlemestrocel-L) in the treatment of patients with ischemic chronic heart failure with reduced ejection fraction (HFrEF) and inflammation, and label extension for Ryoncil^® (remestemcel-L-rknd) in adults with steroid refractory acute graft versus host disease (SR-aGvHD).

Sheridan, WY, June 11, 2025 (GLOBE NEWSWIRE) -- Breakthrough Nura Wallet technology turns crypto staking from 50-exchange nightmare into simple one-click profit machine

Nura Labs, LLC today filed a game-changing patent that could unlock $180 billion in trapped DeFi value. The Company's breakthrough AI technology transforms impossibly complex crypto staking into automated profit generation through the world's first intelligent wallet.

Patent pending — U.S. Provisional Application No. 63/819,482 protects revolutionary algorithms that automatically optimize staking across hundreds of protocols while users simply hold their crypto in the Nura Wallet.

The $180 Billion Problem Finally Solved

Current crypto staking forces users to become day traders across dozens of platforms simultaneously. This complexity locks out 95% of crypto holders from earning passive income on their assets, leaving massive profits on the table. 

"We just eliminated the biggest barrier in crypto," said the Nura Labs team. "The Nura Wallet embeds institutional-grade AI that acts like a personal hedge fund manager, automatically maximizing yields while users sleep."

Patent-Protected Technology Advantage

The 37-claim patent covers three breakthrough innovations:

● Protocol-Specific AI Models that understand each DeFi protocol's unique mechanics

● Predictive Yield Optimization that forecasts market scenarios for maximum returns

● Autonomous Cross-Protocol Management that seamlessly handles complex multi-chain operations

Explosive Performance Results

Real testing delivers game-changing results:

● 23% higher staking yields vs manual management

● 67% lower transaction costs through intelligent execution

● 89% less time required for portfolio optimization

● 2x better risk-adjusted returns through AI diversification

Massive Market Opportunity

With the DeFi market growing 300% annually and less than 10% user penetration due to complexity, Nura Labs is positioned to capture enormous market share through patent-protected technology that makes institutional-grade staking accessible to everyone.

Multiple Revenue Streams

The patent enables lucrative business opportunities:

● Technology licensing to major crypto platforms

● Direct Nura Wallet operations targeting millions of users

● Strategic partnerships with top DeFi protocols

Aggressive Growth Timeline

Q3 2025: Beta launch and strategic partnerships

Q4 2025: Major protocol integrations

Q1 2026: Public launch capturing mainstream market

Q2 2026: International expansion and institutional features

Investment Catalyst

This patent filing creates a defensible competitive moat around the most valuable innovation in DeFi infrastructure. Nura Labs seeks strategic investors and partners to capitalize on this massive market opportunity. 

"We've built the technology that finally makes crypto work for everyone," continued the team. "This patent protects our path to becoming the dominant wallet in the fastest-growing sector of finance."

Contact Information

Corporate Development: investors@nura.gg

Strategic Partnerships: partnerships@nura.gg

Media Inquiries: media@nura.gg

Nura Labs, LLC

30 N Gould St, STE R, Sheridan, WY 82801

Website: https://nura.gg/

Legal Notice

Patent pending — U.S. Provisional Application No. 63/819,482, filed on 06/06/25. Cryptocurrency investments involve substantial risk. Investment opportunities limited to accredited investors.

Disclaimer: The information provided in this press release is not a solicitation for investment, nor is it intended as investment advice, financial advice, or trading advice. It is strongly recommended you practice due diligence, including consultation with a professional financial advisor, before investing in or trading cryptocurrency and securities.

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of PepGen Inc. (NASDAQ: PEPG) between March 7, 2024 and March 3, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 8, 2025.

TORONTO, June 11, 2025 (GLOBE NEWSWIRE) -- Marrelli Capital Limited, a company that Carmelo Marrelli (the “Acquiror”), the CEO of BE Resources Inc. (the “Company”), exercises control and direction over, announces today that it has filed an early warning report in respect of its holdings in the Company. On June 11, 2025, the Acquiror acquired 769,230 common shares of the Company (the “Shares”) by way of private agreement (the “Acquisition”) with a third-party vendor.

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Vestis Corporation (NYSE: VSTS) between May 2, 2024 and May 6, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 8, 2025.

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of American Depositary Shares (“ADSs”) of Reckitt Benckiser Group PLC (OTC: RBGLY) between January 13, 2021 through July 28, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 4, 2025.

TORONTO, June 11, 2025 (GLOBE NEWSWIRE) -- Apollo Technology Capital Corporation (“Apollo Capital”), which together with its affiliates and associates collectively is one of the largest shareholders of MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs”, or the “Company”), owning approximately 3% of the Company’s common stock, today issued a presentation to set forth their ambitious plan to grow your investment and help turn MediPharm around.

LOUISVILLE, Ky., June 10, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (NASDAQ: BTSG) (“BrightSpring” or the “Company”), a leading provider of home and community-based health services for complex populations, today announced the pricing of the previously announced underwritten secondary offering by certain of its stockholders (the “Selling Stockholders”), including affiliates of Kohlberg Kravis Roberts & Co. L.P. (the “KKR Selling Stockholder”) and certain members of management, of an aggregate 14,000,000 shares of common stock of BrightSpring pursuant to a shelf registration statement filed by BrightSpring with the U.S. Securities and Exchange Commission (the “SEC”), at the public offering price of $21.75 per share. The KKR Selling Stockholder has granted the underwriters a 30-day option to purchase up to an additional 2,100,000 shares of BrightSpring’s common stock. No shares are being sold by BrightSpring in the offering. The Selling Stockholders will receive all of the proceeds from this offering. The offering is expected to close on June 12, 2025, subject to customary closing conditions.